| 1 | 
                
                    CD52
                
             💬
 | - | Alemtuzumab 
                
                    Alemtuzumab
                
             💬
 | 
                
                    Alemtuzumab
                
             | [22]  13 13, 15, 19, 20, 36, 43, 44, 46, 49, 51, 60, 62, 63, 65, 85, 96, 164, 234, 283, 284, 285, 326 💬
 | 
| 2 | 
                
                    TNFSF13B
                
             💬
 | [4]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis | Belimumab 
                
                    Belimumab
                
             💬
 | 
                
                    Belimumab
                
             | [13]  11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬
 | 
| 3 | 
                
                    DHFR
                
             💬
 | [5]  One carbon pool by folate One carbon pool by folate, Folate biosynthesis, Metabolic pathways, Biosynthesis of cofactors, Antifolate resistance | Methotrexate 
                
                    Methotrexate
                
             💬
 | 
                
                    Methotrexate
                
             | [38]  11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
 | 
| 4 | 
                
                    DHFR2
                
             💬
 | [5]  One carbon pool by folate One carbon pool by folate, Folate biosynthesis, Metabolic pathways, Biosynthesis of cofactors, Antifolate resistance | Methotrexate 
                
                    Methotrexate
                
             💬
 | 
                
                    Methotrexate
                
             | [38]  11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
 | 
| 5 | 
                
                    NR3C1
                
             💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Prednisolone 
                
                    Prednisolone
                
             💬
 | 
                
                    Prednisolone
                
             | [42]  3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
 | 
| 6 | 
                
                    NR3C1
                
             💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Prednisone 
                
                    Prednisone
                
             💬
 | 
                
                    Prednisone
                
             | [45]  2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬
 | 
| 7 | 
                
                    IL5
                
             💬
 | [13]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Th1 and Th2 cell differentiation, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, Intestinal immune network for IgA production, Pathways in cancer, Asthma, Autoimmune thyroid disease, Inflammatory bowel disease, Allograft rejection | Mepolizumab 
                
                    Mepolizumab
                
             💬
 | 
                
                    Mepolizumab
                
             | [4]  44 44, 45, 98, 162 💬
 | 
| 8 | 
                
                    IL5
                
             💬
 | [13]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Th1 and Th2 cell differentiation, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, Intestinal immune network for IgA production, Pathways in cancer, Asthma, Autoimmune thyroid disease, Inflammatory bowel disease, Allograft rejection | Reslizumab 
                
                    Reslizumab
                
             💬
 | 
                
                    Reslizumab
                
             | [2]  44 44, 98 💬
 | 
| 9 | 
                
                    IL5RA
                
             💬
 | [4]  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer | Benralizumab 
                
                    Benralizumab
                
             💬
 | 
                
                    Benralizumab
                
             | [5]  44 44, 45, 98, 162, 299 💬
 | 
| 10 | 
                
                    IL6R
                
             💬
 | [12]  EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, HIF-1 signaling pathway, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Th17 cell differentiation, Non-alcoholic fatty liver disease, Human cytomegalovirus infection, Coronavirus disease - COVID-19, Pathways in cancer | Tocilizumab 
                
                    Tocilizumab
                
             💬
 | 
                
                    Tocilizumab
                
             | [21]  2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
 | 
| 11 | 
                
                    IMPDH1
                
             💬
 | [4]  Purine metabolism Purine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism | Mycophenolate mofetil 
                
                    Mycophenolate mofetil
                
             💬
 | 
                
                    Mycophenolate mofetil
                
             | [34]  2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
 | 
| 12 | 
                
                    IMPDH1
                
             💬
 | [4]  Purine metabolism Purine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism | Mycophenolic acid 
                
                    Mycophenolic acid
                
             💬
 | 
                
                    Mycophenolic acid
                
             | [36]  2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
 | 
| 13 | 
                
                    IMPDH2
                
             💬
 | [4]  Purine metabolism Purine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism | Mycophenolate mofetil 
                
                    Mycophenolate mofetil
                
             💬
 | 
                
                    Mycophenolate mofetil
                
             | [34]  2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
 | 
| 14 | 
                
                    IMPDH2
                
             💬
 | [4]  Purine metabolism Purine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism | Mycophenolic acid 
                
                    Mycophenolic acid
                
             💬
 | 
                
                    Mycophenolic acid
                
             | [36]  2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
 | 
| 15 | 
                
                    JAK1
                
             💬
 | [27]  EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, PI3K-Akt signaling pathway, Necroptosis, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis C, Hepatitis B, Measles, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19, Pathways in cancer, Viral carcinogenesis, Pancreatic cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer | Tofacitinib 
                
                    Tofacitinib
                
             💬
 | 
                
                    Tofacitinib
                
             | [15]  11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 16 | 
                
                    JAK2
                
             💬
 | [24]  EGFR tyrosine kinase inhibitor resistance EGFR tyrosine kinase inhibitor resistance, Chemokine signaling pathway, PI3K-Akt signaling pathway, Necroptosis, Signaling pathways regulating pluripotency of stem cells, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Cholinergic synapse, Prolactin signaling pathway, Adipocytokine signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Growth hormone synthesis, secretion and action, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis B, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Pathways in cancer, Chemical carcinogenesis - receptor activation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tofacitinib 
                
                    Tofacitinib
                
             💬
 | 
                
                    Tofacitinib
                
             | [15]  11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 17 | 
                
                    JAK3
                
             💬
 | [15]  Chemokine signaling pathway Chemokine signaling pathway, PI3K-Akt signaling pathway, Necroptosis, Signaling pathways regulating pluripotency of stem cells, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Hepatitis B, Measles, Human T-cell leukemia virus 1 infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis, Non-small cell lung cancer, Primary immunodeficiency | Tofacitinib 
                
                    Tofacitinib
                
             💬
 | 
                
                    Tofacitinib
                
             | [15]  11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 18 | 
                
                    OPRD1
                
             💬
 | [3]  cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction | Naltrexone 
                
                    Naltrexone
                
             💬
 | 
                
                    Naltrexone
                
             | [13]  6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
 | 
| 19 | 
                
                    OPRK1
                
             💬
 | [1]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Naltrexone 
                
                    Naltrexone
                
             💬
 | 
                
                    Naltrexone
                
             | [13]  6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
 | 
| 20 | 
                
                    OPRM1
                
             💬
 | [3]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction | Naltrexone 
                
                    Naltrexone
                
             💬
 | 
                
                    Naltrexone
                
             | [13]  6 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226 💬
 | 
| 21 | 
                
                    C5
                
             💬
 | [11]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Vilobelimab 
                
                    Vilobelimab
                
             💬
 | 
                
                    Vilobelimab
                
             | [3]  43 43, 44, 269 💬
 | 
| 22 | 
                
                    C5AR1
                
             💬
 | [6]  Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Alcoholic liver disease, Staphylococcus aureus infection, Coronavirus disease - COVID-19 | Avacopan 
                
                    Avacopan
                
             💬
 | 
                
                    Avacopan
                
             | [3]  43 43, 44, 222 💬
 | 
| 23 | 
                
                    TYK2
                
             💬
 | [16]  Necroptosis Necroptosis, Osteoclast differentiation, NOD-like receptor signaling pathway, JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Hepatitis C, Hepatitis B, Measles, Influenza A, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Coronavirus disease - COVID-19 | Tofacitinib 
                
                    Tofacitinib
                
             💬
 | 
                
                    Tofacitinib
                
             | [15]  11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
 | 
| 24 | 
                
                    MS4A1
                
             💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage | Rituximab 
                
                    Rituximab
                
             💬
 | 
                
                    Rituximab
                
             | [48]  11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
 | 
| 25 | 
                
                    MS4A1
                
             💬
 | [1]  Hematopoietic cell lineage Hematopoietic cell lineage | Obinutuzumab 
                
                    Obinutuzumab
                
             💬
 | 
                
                    Obinutuzumab
                
             | [4]  43 43, 44, 49, 222 💬
 | 
| 26 | 
                
                    CD80
                
             💬
 | [11]  Virion - Adenovirus Virion - Adenovirus, Cell adhesion molecules, Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis | Abatacept 
                
                    Abatacept
                
             💬
 | 
                
                    Abatacept
                
             | [26]  11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 | 
| 27 | 
                
                    CD86
                
             💬
 | [13]  Virion - Adenovirus Virion - Adenovirus, Cell adhesion molecules, Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Kaposi sarcoma-associated herpesvirus infection, Transcriptional misregulation in cancer, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis | Abatacept 
                
                    Abatacept
                
             💬
 | 
                
                    Abatacept
                
             | [26]  11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
 |